Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.80 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.80 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.73 |
| ▸ | ATM | Q13315 | 1/20 | 0.73 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.37 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL1696946 | 0.95 | — | — | |
| Tetrylammonium SCHEMBL11162171 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL1933478 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL1933475 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL761757 | 0.95 | — | — | |
| Tetrylammonium SCHEMBL23528606 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL6396733 | 0.90 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL1270066 | 0.90 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL6396737 | 0.90 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL63891 | 0.90 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1816120-A1 | Aminonitrile production | INVISTA Technologies S.à.r.l. (US) | 2007-08-08 | — | — | EP | claimed |
| EP-1434758-A1 | AMINONITRILE PRODUCTION | INVISTA Technologies S.à.r.l. (US) | 2004-07-07 | — | — | EP | claimed |
| WO-2003029192-A1 | AMINONITRILE PRODUCTION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-04-10 | — | — | WO | claimed |
| US-6455723-B1 | Aminonitrile production | E. I. DU PONT DE NEMOURS AND COMPANY | 2002-09-24 | — | — | US | claimed |
| US-11254692-B2 | Method for producing trichlorosilylsulfide anion and its use in the preparation of organosulfur compounds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-02-22 | — | — | US | disclosed |
| US-20210130375-A1 | METHOD FOR PRODUCING TRICHLOROSILYLSULFIDE ANION AND ITS USE IN THE PREPARATION OF ORGANOSULFUR COMPOUNDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-05-06 | — | — | US | disclosed |
| EP-1816120-A1 | Aminonitrile production | INVISTA Technologies S.à.r.l. (US) | 2007-08-08 | — | — | EP | disclosed |
| EP-1434758-A1 | AMINONITRILE PRODUCTION | INVISTA Technologies S.à.r.l. (US) | 2004-07-07 | — | — | EP | disclosed |
| WO-2003029192-A1 | AMINONITRILE PRODUCTION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-04-10 | — | — | WO | disclosed |
| US-6455723-B1 | Aminonitrile production | E. I. DU PONT DE NEMOURS AND COMPANY | 2002-09-24 | — | — | US | disclosed |
| US-5013337-A | Process for separating a mixture of molecular species using crystalline microporous metal sulfide compositions | UOP (US) | 1991-05-07 | — | — | US | disclosed |
| US-4933068-A | Hydrocarbon conversion process using crystalline microporous metal sulfide compositions | UOP (US) | 1990-06-12 | — | — | US | disclosed |
| US-4880761-A | AMINE TEMPLATING AGENT, GERMANIUM OR TIN SULFIDES, SELENIDES | UOP (US) | 1989-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11254692-B2 | Method for producing trichlorosilylsulfide anion and its use in the preparation of organosulfur compounds | TST, CBS, CTH | TSHR 842/4885NFKB1 4784/4885KCNA1 3471/4885 |
| US-20210130375-A1 | METHOD FOR PRODUCING TRICHLOROSILYLSULFIDE ANION AND ITS USE IN THE PREPARATION OF ORGANOSULFUR COMPOUNDS | TST, CBS, CTH | TSHR 842/4885NFKB1 4784/4885KCNA1 3471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.